mecamylamine
Selected indexed studies
- Mecamylamine: new therapeutic uses and toxicity/risk profile. (Clin Ther, 2001) [PMID:11354389]
- Mecamylamine (a nicotine antagonist) for smoking cessation. (Cochrane Database Syst Rev, 2000) [PMID:10796584]
- Nicotine-mecamylamine interactions. (Clin Pharmacol Ther, 2000) [PMID:10945316]
_Worker-drafted node — pending editorial review._
Connections
mecamylamine is a side effect of
Sources
- Mecamylamine: new therapeutic uses and toxicity/risk profile. (2001) pubmed
- Mecamylamine (a nicotine antagonist) for smoking cessation. (2000) pubmed
- Nicotine-mecamylamine interactions. (2000) pubmed
- Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders. (2009) pubmed
- Mecamylamine (Inversine): an old antihypertensive with new research directions. (2002) pubmed
- Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics. (2019) pubmed
- Potential therapeutic uses of mecamylamine and its stereoisomers. (2013) pubmed
- TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. (2008) pubmed
- Mecamylamine inhibits seizure-like activity in CA1-CA3 hippocampus through antagonism to nicotinic receptors. (2021) pubmed
- Mecamylamine (Targacept). (2006) pubmed